Elsevier provides free access to research and clinical resources via Mpox Information Center to accelerate fight against viral disease

For the benefit of healthcare professionals, researchers and the public in the fight against mpox, Elsevier, a global leader in scientific information and analytics, has today relaunched its Mpox Information Center.

In response to the World Health Organization (WHO) recently declaring mpox a public health emergency of international concern (PHEIC), Elsevier’s Mpox Information Center provides free access to all mpox-related information across Elsevier’s journals, medical books and clinical resources. It will be continuously updated with the latest research and clinical information on the viral disease and its treatment. Over 1,700 mpox-related research articles and book chapters published by Elsevier are now freely available on ScienceDirectopens in new tab/window, Elsevier’s world leading platform of peer-reviewed scholarly literature. The content will be machine-readable to enable researchers to use text and data mining technologies to identify patterns and relationships in the data.

Esra Erkal, EVP, Communications for Elsevier, said: “The Elsevier Mpox Information Center supports healthcare professionals, researchers, policy makers and the public by bringing together the latest knowledge related to mpox in one place so that best efforts can be made towards awareness, prevention and treatment. As we have done in previous public health emergencies, we will continually update the Information Center to help accelerate the fight against this devastating virus.”

The Mpox Information Center provides free access to content curated in consultation with Elsevier clinicians and other experts. It brings together content from the company’s scientific journals, medical books, monographs and clinical information solutions as well as resources from other information providers and major health and government organizations including WHO and the U.S. Centers for Disease Control and Prevention. Information typically used by practicing nurses and physicians, plus resources designed specifically for patients and their families, is also available.

These various resources will continue to be made available for as long as the mpox public health emergency is ongoing. Our response to mpox follows that of previous healthcare emergencies such as Ebola, SARS, Zika, MERS, and Coronavirus.

About Elsevier

エルゼビアは、先端情報と意思決定支援の分野におけるグローバルリーダーです。1世紀以上にわたり、科学と医療の発展を通じて人類の進歩に貢献してきました。世界170か国において、学術・企業の研究コミュニティ、医師、看護師、将来の医療従事者、教育関係者の重要な活動を支援しています。エルゼビアは、世界有数のエビデンスに基づく科学・医学コンテンツ、精度の高いAI、そして専門家による評価を基盤とした研究・臨床レベルのソリューションを提供し、より良い成果の実現を支援しています。また、サービスを提供するコミュニティと連携しながら、多様性とサステナビリティの推進にも取り組んでいます。エルゼビア財団opens in new tab/window（Elsevier Foundation）は、世界各地における研究および医療分野のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールを提供するグローバル企業、RELXopens in new tab/windowの一員です。詳細については、https://www.elsevier.com/ja-jp をご覧いただくか、ソーシャルメディアの @elsevierconnect をご参照ください。